Welcome to Raimondo’s Research Lab
Our research is broadly focused on the design of targeted drug-delivery vectors and novel RNA-based therapeutics for applications in cancer, immunotherapy, and tissue regeneration.
Dr. Raimondo is guest editing a methods collection in JoVE! Now open for submissions.
The title of the collection is “Current Methods for the Development and Assessment of Nucleic Acid-Based Regenerative Immunotherapies.”
This collection compiles methods surrounding the design, optimization, and assessment of nucleic acid-based regenerative technologies. These include, but are not limited to:
• polymeric, lipid, and inorganic nanomaterials
• hydrogel, polymer, and scaffold-based materials for nucleic acids
• nucleic acid-based targeted delivery
• barcoding, machine learning, and spatial transcriptomics for therapeutic optimization
• the fabrication of novel nucleic acid constructs
Please click here to submit your abstract. The deadline for abstract submission is March 29, 2025.